Clinical Application Guidelines on Chinese Patent Medicine In the Treatment for Rheumatoid arthritis

Title: Clinical Application Guidelines on Chinese Patent Medicine In the Treatment for Rheumatoid arthritis
Edition: Original
Classification: Traditional Chinese Medicine guideline
Field: Diagnosis and Treatment
Countries and regions: China
Guidelines users: Western medicine specialists, general practitioners, clinical pharmacology and nursing staff in general hospitals who want to use Chinese patent medicine to treat rheumatoid patients.
Evidence classification method: GRADE:The Grade of Recommendation,Assessment,Development and Evaluation
Development unit: 中国中药协会
Registration time: 2022-11-22
Registration number: PREPARE-2022CN765
Purpose of the guideline: The compilation of Clinical Application Guidelines on Chinese Patent Medicine In the Treatment for Rheumatoid arthritis aims to standardize and promote the application of Chinese patent drugs in the treatment of rheumatoid arthritis, improve the treatment level of rheumatoid arthritis and reduce the burden of disease.